References
- van der Neut Kolfschoten M, Schuurman J, Losen M, Bleeker WK, Martínez-Martínez P, Vermeulen E, et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 2007; 317:1554 - 7; http://dx.doi.org/10.1126/science.1144603; PMID: 17872445
- Pandey JP. Fab-arm exchange is a misnomer. MAbs 2012; 4:553 - 4; http://dx.doi.org/10.4161/mabs.21311; PMID: 22889961
- Labrijn AF, Rispens T, Meesters J, Rose RJ, den Bleker TH, Loverix S, et al. Species-specific determinants in the IgG CH3 domain enable Fab-arm exchange by affecting the noncovalent CH3-CH3 interaction strength. J Immunol 2011; 187:3238 - 46; http://dx.doi.org/10.4049/jimmunol.1003336; PMID: 21841137
- Lewis KB, Meengs B, Bondensgaard K, Chin L, Hughes SD, Kjaer B, et al. Comparison of the ability of wild type and stabilized human IgG(4) to undergo Fab arm exchange with endogenous IgG(4)in vitro and in vivo. Mol Immunol 2009; 46:3488 - 94; http://dx.doi.org/10.1016/j.molimm.2009.07.009; PMID: 19683345
- Wang W, Xu R, Li J. Production of native bispecific antibodies in rabbits. PLoS One 2010; 5:e10879; http://dx.doi.org/10.1371/journal.pone.0010879; PMID: 20559427
- Brusco A, Saviozzi S, Cinque F, DeMarchi M, Boccazzi C, de Lange G, et al. Molecular characterization of immunoglobulin G4 gene isoallotypes. Eur J Immunogenet 1998; 25:349 - 55; http://dx.doi.org/10.1046/j.1365-2370.1998.00113.x; PMID: 9805657
- Bumbaca D, Boswell CA, Fielder PJ, Khawli LA. Physiochemical and biochemical factors influencing the pharmacokinetics of antibody therapeutics. AAPS J 2012; 14:554 - 8; http://dx.doi.org/10.1208/s12248-012-9369-y; PMID: 22610647
- Jefferis R. Glycosylation as a strategy to improve antibody-based therapeutics. Nat Rev Drug Discov 2009; 8:226 - 34; http://dx.doi.org/10.1038/nrd2804; PMID: 19247305